Lilly Asia, HongShan et al to Exit from ProfoundBio
08 Apr 2024
US$ 19.00
Lilly Asia Ventures, HongShan, LYFE Capital, K2 Venture Partners and Gaorong Ventures are to conclude their investment...
Related Publications
Subscribers’ Weekly for the week ending 3 Apri 2026...
Listen to Subscribers' Weekly 03 Apr 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.